171 related articles for article (PubMed ID: 34135089)
21. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
[TBL] [Abstract][Full Text] [Related]
22. Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen.
Watanabe A; Fukami T; Takahashi S; Kobayashi Y; Nakagawa N; Nakajima M; Yokoi T
Drug Metab Dispos; 2010 Sep; 38(9):1532-7. PubMed ID: 20542992
[TBL] [Abstract][Full Text] [Related]
23. Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells.
Gabriele M; Puccini P; Gervasi PG; Longo V
Life Sci; 2021 Jul; 277():119486. PubMed ID: 33864822
[TBL] [Abstract][Full Text] [Related]
24. Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro.
Imai S; Ichikawa T; Sugiyama C; Nonaka K; Yamada T
J Pharm Sci; 2019 Feb; 108(2):1027-1034. PubMed ID: 30267780
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of the oxidation of propranolol enantiomers in hepatic and small intestinal microsomes from cynomolgus and marmoset monkeys.
Shimizudani T; Nagaoka K; Hanioka N; Yamano S; Narimatsu S
Chem Biol Interact; 2010 Jan; 183(1):67-78. PubMed ID: 19853591
[TBL] [Abstract][Full Text] [Related]
26. Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues.
Hammid A; Fallon JK; Lassila T; Vieiro P; Balla A; Gonzalez F; Urtti A; Smith PC; Tolonen A; Honkakoski P
Drug Metab Dispos; 2022 Dec; 50(12):1483-1492. PubMed ID: 36195336
[TBL] [Abstract][Full Text] [Related]
27. Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine.
Nakajima A; Fukami T; Kobayashi Y; Watanabe A; Nakajima M; Yokoi T
Biochem Pharmacol; 2011 Dec; 82(11):1747-56. PubMed ID: 21856291
[TBL] [Abstract][Full Text] [Related]
28. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
Laizure SC; Parker RB; Herring VL; Hu ZY
Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
[TBL] [Abstract][Full Text] [Related]
29. N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity.
Muta K; Fukami T; Nakajima M; Yokoi T
Biochem Pharmacol; 2014 Jan; 87(2):352-9. PubMed ID: 24125761
[TBL] [Abstract][Full Text] [Related]
30. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
31. Identification and Characterization of a New Carboxylesterase 2 Isozyme, mfCES2C, in the Small Intestine of Cynomolgus Monkeys.
Ohura K; Igawa Y; Tanaka M; Matsumoto K; Kasahara A; Wada N; Kubota K; Uno Y; Imai T
Drug Metab Dispos; 2020 Mar; 48(3):146-152. PubMed ID: 31836607
[TBL] [Abstract][Full Text] [Related]
32. Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny.
Hines RN; Simpson PM; McCarver DG
Drug Metab Dispos; 2016 Jul; 44(7):959-66. PubMed ID: 26825642
[TBL] [Abstract][Full Text] [Related]
33. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
Thomsen R; Rasmussen HB; Linnet K;
Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
[TBL] [Abstract][Full Text] [Related]
34. A New Marmoset P450 4F12 Enzyme Expressed in Small Intestines and Livers Efficiently Metabolizes Antihistaminic Drug Ebastine.
Uehara S; Uno Y; Yuki Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jun; 44(6):833-41. PubMed ID: 27044800
[TBL] [Abstract][Full Text] [Related]
35. A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity.
Shimizu M; Fukami T; Kobayashi Y; Takamiya M; Aoki Y; Nakajima M; Yokoi T
Drug Metab Dispos; 2012 Jun; 40(6):1183-90. PubMed ID: 22415931
[TBL] [Abstract][Full Text] [Related]
36. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
Sato Y; Miyashita A; Iwatsubo T; Usui T
Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
[TBL] [Abstract][Full Text] [Related]
37. Examination of the carboxylesterase phenotype in human liver.
Ross MK; Borazjani A; Wang R; Crow JA; Xie S
Arch Biochem Biophys; 2012 Jun; 522(1):44-56. PubMed ID: 22525521
[TBL] [Abstract][Full Text] [Related]
38. Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues.
Hammid A; Fallon JK; Lassila T; Salluce G; Smith PC; Tolonen A; Sauer A; Urtti A; Honkakoski P
Mol Pharm; 2021 Mar; 18(3):1305-1316. PubMed ID: 33595329
[TBL] [Abstract][Full Text] [Related]
39. Arylacetamide Deacetylase Enzyme: Presence and Interindividual Variability in Human Lungs.
Gabriele M; Puccini P; Lucchi M; Aprile V; Gervasi PG; Longo V
Drug Metab Dispos; 2019 Sep; 47(9):961-965. PubMed ID: 31235486
[TBL] [Abstract][Full Text] [Related]
40. Hydrolytic metabolism of phenyl and benzyl salicylates, fragrances and flavoring agents in foods, by microsomes of rat and human tissues.
Ozaki H; Sugihara K; Tamura Y; Fujino C; Watanabe Y; Uramaru N; Sone T; Ohta S; Kitamura S
Food Chem Toxicol; 2015 Dec; 86():116-23. PubMed ID: 26321725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
